Brief: Aptorum Group Files For Mixed Shelf Of Upto $100 Mln - SEC Filing
Brief: Aptorum Group Files For Mixed Shelf Offering Of Up To $100 Million - SEC Filing
Brief: Aptorum Group Ltd Files Prospectus Relates To Resale Of Up To 27.8 Million Class A Ordinary Shares By Selling Shareholders
Brief: Aptorum Group Says Existing Cash, Marketable Securities Will Enable It To Fund Its Operating And Capital Expenditure Requirements To End Of 2020
Brief: Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate
Brief: Aptorum Group Ltd Announces Development Of Two Preclinical Drug Candidates Which Target Obesity And Neuroblastoma, Respectively
U.S. STOCKS ON THE MOVE-Plug Power, Marriott, Insulet
Brief: Aptorum Group Files Prospectus Related To Resale By Selling Shareholder Of Upto 27.8 Mln Class A Ordinary Shares
Working Laboratory Ecosystems For Life Sciences Start-Ups In United States
Create Local Deep Tech Start-Ups In Healthcare And Life Sciences Sector
Brief: Aptorum Group Repurchases Outstanding $13.5 Mln In Aggregate Principal Amount Of 8 Percent Convertible Bonds From Peace Range Limited
Brief: Darren Lui Reports A 19.6 Percent Stake In Aptorum Group As Of Dec 17, 2018
Brief: Aptorum Group Shares Open At Par In Debut On Nasdaq At $15.80 Per Share
NASDAQ RESUMED
NASDAQ TRADE HALT REASON NOT AVAILABLE